Ofev (nintedanib) causes diarrhea because it blocks growth factor signals that your intestinal lining depends on to maintain and repair itself. It’s the most common side effect of the drug, affecting 62% of patients with idiopathic pulmonary fibrosis (IPF) and up to 76% of patients with systemic sclerosis-related lung disease in clinical trials. The diarrhea isn’t a random quirk of the medication. It’s a direct consequence of how the drug works.
How Ofev Disrupts the Gut Lining
Ofev is a tyrosine kinase inhibitor, which means it blocks specific signaling proteins that drive tissue scarring in the lungs. The three main targets are receptors for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). Blocking these receptors is what slows lung fibrosis, but these same proteins play important roles in the gut.
PDGF and FGF help regulate the constant turnover of cells lining the intestine. Your gut lining replaces itself every few days, and when the signals driving that renewal are suppressed, intestinal cells can die off faster than they’re replaced. This is similar to what happens with other cancer and fibrosis drugs that target growth factor receptors. The result is a thinner, more fragile intestinal barrier that doesn’t absorb water and nutrients as efficiently.
VEGF, the third target, maintains the tiny blood vessels running through the intestinal wall and pancreas. When Ofev blocks VEGF signaling, blood flow to the intestinal lining can be reduced, creating a form of mild ischemia (reduced oxygen supply). This can produce symptoms resembling a low-grade inflammatory colitis. Reduced blood flow to the pancreas may also impair fat digestion, contributing to loose, fatty stools.
When Symptoms Typically Start
Most people who develop diarrhea on Ofev notice it within the first three months of treatment. The episodes are primarily mild to moderate in intensity. For many patients, the worst of it happens early and then either improves or becomes more manageable as the body adjusts, though some people experience persistent symptoms throughout treatment.
Compared to placebo groups in clinical trials, the difference is significant. In IPF studies, 62% of patients on Ofev reported diarrhea versus 18% on placebo. In patients with systemic sclerosis-related lung disease, the gap was even wider: 76% versus 32%. These numbers make clear that diarrhea isn’t just coincidental. It’s driven by the drug itself.
Dietary Changes That Help
What you eat while taking Ofev can make a meaningful difference in how severe your symptoms are. Several categories of food tend to worsen diarrhea and are worth limiting or avoiding:
- Spicy foods like salsa and curries
- Greasy or fried meals
- Dairy products including milk and cheese
- Caffeine and alcohol
- Insoluble fiber such as raw vegetables, whole grains, and bran
- Sugar-free candies containing xylitol
- Grapefruit and grapefruit juice (which also interfere with how the drug is metabolized)
The BRAT diet, consisting of bananas, white rice, applesauce, and toast, can help during flare-ups. These foods are low in fat, protein, and fiber, making them easy to digest while helping firm up stools. Soluble fiber sources like oatmeal, bananas, and applesauce are generally better tolerated than insoluble fiber and can actually help with stool consistency.
Staying hydrated is critical. Diarrhea pulls fluid from your body quickly, and chronic loose stools can lead to dehydration before you realize it. Drinking extra water throughout the day helps offset those losses.
Why Taking Ofev With Food Matters
Ofev should be swallowed whole with liquid during a full meal. Taking it with food increases the amount of active drug your body absorbs by about 20% compared to taking it on an empty stomach. Meals higher in protein can further improve absorption because the drug binds to proteins once inside your body. Eating a substantial meal also provides a buffer in the stomach that may reduce the intensity of gastrointestinal symptoms, though it won’t eliminate them entirely.
Managing Persistent Diarrhea
Over-the-counter anti-diarrheal medications like loperamide are commonly used as a first-line approach for Ofev-related diarrhea. If symptoms are severe or don’t respond to standard management, your prescriber may reduce the dose from 150 mg twice daily to 100 mg twice daily. In some cases, treatment may be temporarily paused to let symptoms resolve before restarting.
For patients who don’t respond well to loperamide, there is some clinical evidence that medications originally designed to treat nausea by blocking serotonin receptors in the gut can help. Serotonin plays a role in stimulating intestinal contractions and fluid secretion, and blocking that pathway may reduce the frequency and urgency of diarrhea episodes in patients where standard approaches fall short.
The key reality with Ofev-related diarrhea is that it stems from the same mechanism that makes the drug effective. The growth factor pathways it blocks in the lungs are also active in the gut, and there’s no way to target one without affecting the other. For most patients, the symptoms are manageable with dietary adjustments, hydration, and anti-diarrheal medication, particularly after the initial months of treatment.